Collaborative standardisation and SEP Licensing: a EU policy perspective / G. Bruzzone & S. Capozzi -- Economic considerations on mergers, IPR licensing and litigation : A EU perspective / C. Caffarra & P. Régibeau -- Alternative dispute resolution in FRAND licensing : economic considerations...

The January 2012 decision of the Italian Competition Authority (“ICA”) to fine Pfizer and Pharmacia €10.6 million is an illustration of the more aggressive trend taken by competition authorities in the pharmaceutical sector. In this case, the ICA alleges that the parties sought to delay...